Boies Schiller Flexner LLP is currently facing a lawsuit in Florida state court, where a pharmaceutical mass tort law firm and other parties have alleged breaches of a nondisclosure agreement and interference with existing business relationships. The plaintiffs argue that their complaint is legally sufficient under Florida law, countering Boies Schiller’s motion to dismiss the case. ([law360.com](https://www.law360.com/health/articles/2423391/boies-schiller-must-face-fla-fee-suit-court-told?utm_source=openai))
This legal challenge is part of a series of disputes involving Boies Schiller in Florida. In June 2025, a Florida state court judge denied a motion to disqualify the firm from a lawsuit initiated by pharmaceutical mass tort companies. These companies sought to prevent their former counsel from collecting fees after being dismissed for alleged insufficient representation. ([law360.com](https://www.law360.com/articles/2355933/florida-judge-denies-bid-to-dq-boies-schiller-in-fee-suit?utm_source=openai))
In a separate case, Boies Schiller, along with Dentons, successfully defended against a racketeering lawsuit filed by a former client. The client had accused the firms of misconduct, including fraud and violations of federal racketeering laws. However, in September 2025, Chief U.S. District Judge Laura Taylor Swain dismissed the complaint with prejudice, stating that the plaintiffs’ arguments were legally insufficient. ([jdjournal.com](https://www.jdjournal.com/2025/10/02/boies-schiller-and-dentons-secure-major-win-as-racketeering-suit-from-former-client-dismissed/?utm_source=openai))
These cases highlight the complex legal landscape surrounding attorney-client relationships and fee disputes, particularly in the context of mass tort litigation. The outcomes of these proceedings may have significant implications for law firms and their clients, emphasizing the importance of clear agreements and adherence to professional standards.